SYDNEY PEEK: Open Payments
NPI 1518538115 · PARIS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 18 payments from 6 companies in 2025. Trend: 2023 $81 · 2024 $416 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 9 | $274 |
| Novo Nordisk Inc | 3 | $57 |
| Corcept Therapeutics | 2 | $46 |
| ConvaTec Inc. | 1 | $42 |
| BioWound Solutions, Inc. | 2 | $30 |
| Lilly USA, LLC | 1 | $15 |
Products named: DAXXIFY, Korlym, Wegovy, INNOVAMATRIX AC, bio-ConneKt, MOUNJARO.
Industry payments across TX — which companies pay providers there.
